Spero Therapeutics, Inc. (NASDAQ:SPRO) Sees Significant Decline in Short Interest

Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Free Report) was the recipient of a large drop in short interest in January. As of January 15th, there was short interest totalling 680,200 shares, a drop of 13.8% from the December 31st total of 789,000 shares. Based on an average daily volume of 171,200 shares, the days-to-cover ratio […]

Related Keywords

United States , ,Mackenzie Financial Corp ,Nasdaq ,Spero Therapeutics Company Profile ,Spero Therapeutics Inc ,Royce Associates ,Acadian Asset Management ,Cantor Fitzgerald ,Virtu Financial ,Spero Therapeutics ,Get Free Report ,Asset Management ,Funds Management ,Financial Corp ,Therapeutics Stock Down ,Spero Therapeutics Daily ,Nasdaq Spro ,Aspro ,Medical ,Stocks ,Options ,Put ,Call ,